Bacterial Infections of the CNS Flashcards

1
Q

What are the major agents of infectious meningitis?

A
  • Pnemococcus
  • Group B Strep
  • Meningococcus
  • H. influenzae
  • Syphilis
  • Lyme
  • TB
  • Listeria
  • Fungi
  • Enterobacteriaceae
  • Pseudomonas
  • Viruses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the classic symptoms of meningitis?

A
  • headache
  • fever
  • photophobia
  • stiff neck
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How does pediatric meningitis present?

A
  • fever- cold hands and feet
  • refusing food or vomiting
  • fretful, dislike being handled
  • pale blotchy skin
  • blank, staring
  • drowsy
  • stiff neck
  • high pitched
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the bacteriology of Neisseria meningitidis?

A
  • gram neg Diplococci, facultative intracellular
  • human restricted
  • encapsulated
  • 13 serotypes
  • oxidase+
  • catalyse+
  • ferments glucose and maltose, NOT sucrose or lactose
  • growth inhibited by trace metals and fatty acids use chocolate agar not blood agar
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the pathogenesis of N meningitidis?

A
  • transmitted by airborne droplets
  • colonize nasopharnyx (only reservoir)
  • asymptomatic carrier, common in prisons, dorms, military, family of index case
  • spread and colonization may be enhanced by concomitant upper respiratory viral infections
  • infection often resolves without symptoms: IgG complement and neutrophils defend, leave lifelong immunity to infecting strain (individuals with def in C5-C9 predisposes spread to beyond resp system
  • many have natural immunity by age 20; immune mothers passively immunize newborns
  • most common 2-18 years of age
  • colonize favorite sites once meningococcemia: joints (septic arthritis), meninges (fatal if untreated or leave damage with treatment)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the virulence factors of N meningitidis?

A
  • IgA Protease: cleaves IgA, reduces defense of mucus membrane
  • Polysaccharide capsule: resists phagocytosis
  • Endotoxin LOS (component of Gram neg cell wall, cause fever or shock)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does N. meningitidis look like on exam?

A
  • 1/3 cases adult, 2/3 peds
  • septic arthritis: joint pain- draw joint fluid
  • meningitis: adults: classic fever, headache, stiff neck, progression to coma is bad
  • young children: irritability, convulsions, lassitude, fever, abdominal discomfort/vomiting
    both: draw CSF (tap between L3 and L4), admit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How does Meningococcemia look on exam?

A
  • fever and hourly-spreading petehcnial skin rash (may be hard to see on dark skin; will eventually be followed by gangrene)
  • rarely may be present for weeks before symptoms become alarming
  • 5-15% develop Waterhouse-Friderichen syndrome: high fever, shock, widespread purpura, DIC, thrombocytopenia, destruction of adrenal glands (50% fatal)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How does N. meningitidis look on labs?

A
  • Septic arthritis: joint fluid: gram stain and culture on chocolate agar
  • Meningitis: CSF: increased PMNs, Gram stain (50% sensitive) and culture on chocolate agar, Gram neg cocci in CSF smear, or latex agglutination test for capsule polysaccharide in CSF
  • Meningococcemia: Blood- gram stain and culture on chocolate agar, set of tests for DIC
  • PCR test (targets meningitidis specific DNA insertion sequence in blood buffy coat samples: no lumbar puncture!)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do you distinguish between N. meningitidis and N gonnorrhoeae?

A
  • only meningococci ferments maltose

- alternatively theres IF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do you treat N. meningitidis?

A
  • Penicillin G unless allergic or local history of drug resistance
  • Alternatives: Ceftriaxone, cefotaxime, and cefuroxime; if severely allergic to penicillin, choloramphenicol
  • Fulminant meningococcemia: admit to ICU, support circulation and renal function
  • NO STEROIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can n. meningitidis be prevented?

A
  • close contacts of index case got prophylatic rifampin, ceftriaxone, or ciprofloxacin (excreted efficiently into saliva)
  • vaccines recommended for travelers (Mecca outbreaks), college/boarding school students, 11-12 year olds, not suitable for <2 years
  • unconjugated= Menomune
  • conjugated= Menactra
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the bacteriology of Group B strep?

A
  • GBS- S. agalactiae
  • encapsulated Gram positive cocci
  • beta hemolytic
  • polysaccharide toxin virulence factor
  • pilus-like attachment virulence factor
  • serotype specific antibody mediated immunity
  • normal vaginal flora (15-45%) transmits to neonate shortly before and during delivery
  • may also be normal flora in GI and upper resp tract
  • very seldom causes disease in previously healthy adults; may cause bacteremia, cellulitis, UTI with predisposing factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neonate GBS

A
  • 1-2% of neonates of GBS mothers develop invasive disease
  • most common cause of neonatal sepsis
  • usually serotype 3 (of 10)
  • Early disease: pneumonia with bacteremia, presents 1-7d postpartum, prevented by intrapartum IV antibiotics
  • Late disease- bacteremia with meningitis, presents 1-12wk postpartum
  • prematurity and prolonged rupture of membranes are risk factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What other group is effected by GBS?

A
  • -may be seen in geriatric patients with diabetes, malignancy, CHF
  • these rare infections seem to be becoming more common; probably both improved reporting and also population becoming older, more diabetic, more immunosuppressed
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What does GBS look like on exam?

A
  • patients presents with pain, fever, other symptoms specific to site
  • meningitis: spinal tap for gram+ cocci in pairs or short chains
  • cellulitis, abscess: gram stain and culture of appropriate sample (tissue biopsy, aspirate)
  • CT/MRI for deep abscesses
  • echo for endocarditis
17
Q

What is the lab test of GBS?

A
  • CAMP test: CAMP factor secreted by B group strep (and Listeria) enhances activity of Beta hemolysin from S aureus
  • Hippurase/Hippurate Test: colorimetric test for hippurase, produced by GBS, Gardnerella vaginalis, Campylobacter jejuni, Listeria monocytogenes
18
Q

What is the treatment for GBS?

A
  • IV penicillin or amoxicillin
  • if allergic vancomycin
  • surgical intervention may be needed: heart valve replacement for endocarditis, abscess removal for cellulitis, amputation for diabetic foot
19
Q

How do we prevent GBS?

A
  • test term pregnant patients for GS by swab and culture. If positive:
  • Intrapartum (during delivery) IV of penicillin or amoxicllin
  • if allergic use clindamycin or erythromycin, but resistant strains exist
  • strategy has reduced early disease in US over past decade, but there are questions about the sensitivity of the culture and PCR tests
20
Q

What is the bacteriology of Pneumococcus?

A
  • Strep penumonaiae
  • gram+, catalase-, facultative anaerobe
  • in culture, form diplococci in chains
  • pathogenic strains are encapsulated
  • the most common cause of community acquired pneumonia, bacterial meningitis, bacteremia, and otitis media as well as an important cause of sinusitis, septic arthritis, osteomyelitis, peritonitis, and endocarditis
  • a major childhood pathogen worldwide with deaths from pneumonia and meningitis
21
Q

What is the pathogeneis of Pneumococcus?

A
  • easily colonize upper resp tract using adhesion virulence factors (20-50% carriage rates in general population)
  • infections peak in Fall and Winter, when carrier congregate more closely
  • in healthy adults and older children, contained by innate immunity
  • in young children, or in patients with preexisting asthma, allergies, bronchitis, smoking, COPD, bacteria can spread
22
Q

What are the two ways Pneumococcus can spread?

A
  • Direct extension: sinuses, eustachian tubes, bronchi
  • Hematogenous spread: blood joint fluid, peritoneum, CSF
  • capsule protects bacterium against phagocytosis and classic complement unless anti-capsule IgG present
  • pathogenic strains produce pneumolysin, some produce hemolysin, neuraminidase, hyaluronidase, but exact contribution of these exotoxins to pathogenesis is unclear
  • infection raises a strong inflammatory response, which underlies most of the clinical disease symptoms
23
Q

What does Pneumococcus look like on exam (direct extension)?

A
  • diseases of direct extension (non-invasive)- sinusitis, otitis media, bronchitis, pneumonia
  • pneumonia causes significant morbidity and mortality (10-20%)
  • patient looks ill, anxious
  • predispositions: asthma, COPD, chronic bronchitis, smoking or frequent exposure to cigarette smoke
  • can hear rales in most patients dullness to percussion in half
  • on radiology: adolescents and adult- lobar consolidation; infants and young children: scattered parenchemyal consolidation, bronchopneumonia
24
Q

What does Pneumococcus look like on exam (hematogenous spread)?

A
  • meningitis, septic arthritis, pericarditis, endocarditis, osteomyelitis
  • bimodal distribution, younger than 5 older than 65, also anyone immunosuppresed
  • meningitis develops over hours or days, neurologic signs are often prominent (admit for antibiotics and MRI)
  • mental status changes
  • lethargy
  • delirium
  • Brudzinski(+)
  • cranial nerve palsies
  • focal neurologic defects
25
Q

How does Pneumococcus look on lab?

A

-non-invasive disease: can usually be treated based on exam, optional Gram stain

  • Invasive: gram stain and culture of appropriate samples (blood, sputum, CSP, abscess aspirates or biopsies). Blood cultures usually positive
  • begin antibiotic sensitivity testing
  • urine antigen testing is available, useful for pneumonia in young children who don’t produce enough sputum for testing
26
Q

What meningitis spinal tap findings are typical of bacterial meningitis?

A
  • elevated opening pressure
  • elevated WBC count and neutrophil level
  • elevated protein
  • decreased glucose
  • highly elevated lactic acid
  • gram stain and culture are positive unless antibiotic treatment began > 4 hours prior to tap
27
Q

How to treat non-invasive pneumococcus?

A
  • anything less than severe pneumonia: proceed with treatment using antibiotics that include S. pneumoniae among other probably causes: amoxicillin or cephalosporin for everybody, fluoroquinolones or doxycycline for adults- only, outpatients
  • severe pneumonia: admit, vancomycin becomes another antibiotic option
28
Q

How to treat invasive pneumonoccous?

A
  • admit patient, take samples, start antibiotics, start cultures, perform antibiotic susceptibilty testing on cultures
  • initial antibiotics are vancomycin plus ceftriaxome or cefotaxime
  • if isolate testing comes back resistant, add rifampin, meropenem, or chloramphenical
  • steroids may be used with caution in addition to antibiotics, early in the antibiotics course
  • cellulitis and septic arthritis may require surgical care in addition to antibiotics
29
Q

What are the positives and negatives of pneumococcal antibiotic resistance?

A
  • conferred by mutations changing the bacterial cell wall sites to which the antibiotics bind such that the binding affinity is lowered
  • consequently, an increase in dosage can sometimes overcome resistance for this pathogen. MIC (minimum inhibitory concentration) describes the dosage necessary to kill the patient’s isolate
  • but it is carried on a transposon that includes resistance genes for multiple antibiotics, so if theres resistance to any, probably many
30
Q

How do you prevent pneumonoccous prevention?

A
  • Prevnar7 vaccine raises protective IgG against the capsules of the seven serotypes that most commonly caused invasive disease prior to 2000
  • Universal childhood vaccination with Prevnar7 starting in 2000 knocked down levels of invasive disease 90%
  • childhood causes of invasive diseased caused by those serotypes essentially disappeared (more effective than anyone expected)
  • rates of carriage of those serotypes dropped as herd immunity was achieved
  • rates of disease caused by other serotypes of pneumococcus increased (“replacement disease”
  • Prevnar13 vaccine, providing coverage for original seven plus 6 of the newly problematic serotypes is now available; may be used for childhood vaccination series, may be given as a booster to those who received Prevnar7 series